329 related articles for article (PubMed ID: 10532543)
1. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
[TBL] [Abstract][Full Text] [Related]
3. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
Kirk AD; Tadaki DK; Celniker A; Batty DS; Berning JD; Colonna JO; Cruzata F; Elster EA; Gray GS; Kampen RL; Patterson NB; Szklut P; Swanson J; Xu H; Harlan DM
Transplantation; 2001 Aug; 72(3):377-84. PubMed ID: 11502964
[TBL] [Abstract][Full Text] [Related]
4. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
5. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
[TBL] [Abstract][Full Text] [Related]
6. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
7. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
[TBL] [Abstract][Full Text] [Related]
8. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice.
Kano M; Bashuda H; Yagita H; Okumura K; Morishita Y
Transplantation; 1998 Mar; 65(6):837-43. PubMed ID: 9539097
[TBL] [Abstract][Full Text] [Related]
9. Blocking of costimulation prevents kidney graft rejection in rhesus monkeys.
Ossevoort MA; Ringers J; Boon L; Lorré K; van den Hout Y; Kuhn EM; de Boer M; Jonker M; de Waele P
Transplant Proc; 1998 Aug; 30(5):2165-6. PubMed ID: 9723429
[No Abstract] [Full Text] [Related]
10. Anergic T cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.
Denton MD; Geehan CS; Alexander SI; Sayegh MH; Briscoe DM
J Exp Med; 1999 Aug; 190(4):555-66. PubMed ID: 10449526
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
14. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
[TBL] [Abstract][Full Text] [Related]
15. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
16. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
[TBL] [Abstract][Full Text] [Related]
18. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
19. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.
Yuan X; Salama AD; Dong V; Schmitt I; Najafian N; Chandraker A; Akiba H; Yagita H; Sayegh MH
J Immunol; 2003 Mar; 170(6):2949-55. PubMed ID: 12626546
[TBL] [Abstract][Full Text] [Related]
20. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]